Company intelligence / Profile preview

Azure Biosystems

Dublin, California, United Statesazurebiosystems.com ↗

Ownership: Private
Development stage: Commercial

Overview

Azure Biosystems develops and commercializes advanced imaging instruments and reagents used in life science research. Their products are widely adopted in academic and industrial labs globally for applications such as Western blotting, gel documentation, nucleic acid/protein quantification, real-time PCR analysis, ELISA assays, and more. The company does not develop therapeutics or diagnostics but enables scientific discovery through high-performance laboratory tools.

Therapeutic areas: Other
Modalities: DeviceReagent (for research use; not therapeutic)
Industry: Non-Drug Biotech

Partnerships

Distributors such as Cambridge Bioscience in the UK

Beyond the preview

Go deeper on Azure Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azure Biosystems.

Explore the full profile